TF and ovarian carcinoma: In this study, we evaluated in situ the expression of TF antigen, a truncated O-glycan that has been reported to be expressed in different tumors, such as ovarian cancer, breast cancer, CRC, and acute lymphoblastic leukemia (T-cell) [42].